SBIR-STTR Award

Mobilemedminder: a Networked Aide for Medication Compliance
Award last edited on: 10/23/19

Sponsored Program
SBIR
Awarding Agency
NIH : NIAAA
Total Award Amount
$615,942
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Huiping Li

Company Information

Limaging LLC

12009 Distant Thunder Trail
Clarksville, MD 21029
   (301) 728-0694
   info@limaging.net
   www.limaging.net
Location: Single
Congr. District: 03
County: Howard

Phase I

Contract Number: 275201000012C-1-0-1
Start Date: 9/30/10    Completed: 9/29/13
Phase I year
2011
Phase I Amount
$499,799
Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to web through wireless. MobileMedMinder will provide the following: 1) automatic or simi-automatic entry of medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directly or through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study at the Ohio State University Medical Center managed by collaborator, Robert M. Guthrie, M.D., is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.

NIH Spending Category:
Alcoholism; Behavioral and Social Science; Bioengineering; Clinical Research; Clinical Trials; Substance Abuse

Project Terms:
Academic Medical Centers; Award; base; behavior change; Car Phone; Caregivers; Chronic Disease; Client; Collaborations; Communication; compliance behavior; Computer software; Contracts; Development; Devices; Diabetes Mellitus; Disease Management; Electronics; Enrollment; Goals; Hypertension; Intake; Internet; Link; Measures; medication compliance; Mental Depression; Methodology; Methods; Monitor; Ohio; Patients; Pharmaceutical Preparations; Phase; Physicians; prototype; Randomized Controlled Trials; Recommendation; Services; Small Business Innovation Research Grant; Social Network; Solutions; Study Subject; System; Testing; Time; trial comparing; usability; voice recognition; Wireless Technology

Phase II

Contract Number: 275201000012C-3-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2012
Phase II Amount
$116,143
Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to the web through a wireless connection. MobileMedMinder will provide the following: 1) automatic or semi-automatic entry of medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directly or through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study at the Ohio State University Medical Center is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.

NIH Spending Category:
Alcoholism; Behavioral and Social Science; Bioengineering; Clinical Research; Clinical Trials; Substance Abuse

Project Terms:
Academic Medical Centers; Award; base; behavior change; Car Phone; Caregivers; Chronic Disease; Client; Collaborations; Communication; compliance behavior; Computer software; Contracts; Development; Devices; Diabetes Mellitus; Disease Management; Electronics; Enrollment; Goals; Hypertension; Intake; Internet; Link; Measures; medication compliance; Mental Depression; Methodology; Methods; Monitor; Ohio; Patients; Pharmaceutical Preparations; Phase; Physicians; prototype; Randomized Controlled Trials; Recommendation; Services; Small Business Innovation Research Grant; Social Network; Solutions; Study Subject; System; Testing; Time; trial comparing; usability; voice recognition; Wireless Technology